Site Search
Google Search
Breaking News: Hawaii Missile Threat Quickly Ruled False Alarm     - | -     Does President Trump Wants To Make Nuclear Weapons Easier To Use     - | -     Over 700 Arrested Over Tunisia Protests     - | -     Los Angeles Man Charged With Manslaughter Over 'Swatting' Death     - | -     South Korea And North Korea Schedule Multi Level Talks In Truce Village     - | -     Anti-Trump March Held in Switzerland's Capital     - | -     GOP Congressman Invokes 'The Deep State'
CRISPR Study Sends Biotech Stocks Tumbling
Get Business & Technology Alerts

10 Jan 2018 06:09 AM EST

On Monday, a new paper had identified a possible barrier to using the revolutionary gene-editing tool CRISPR in humans. The news sent the stocks of all three major CRISPR biotech firms tumbling in premarket trading. They declined by as much as 11.9 percent.
In recent years, CRISPR has been credited with the potential power to correct any number of devastating diseases. Researchers have used it to cure mice of deadly genetic conditions like hemophilia B, Lou Gehrig’s disease, and Huntington’s disease. In the U.S., the first human CRISPR trials are slated to begin this year.

Post Your Comment
Excellent Very Good Good Fair Poor



Recently Posted Comments
FREE
AllMediaNY AllMediaNY AllMedaiNY